Tamara L. Lotan - Concepedia

Author

Tamara L. Lotan

Also Known As

Athanase Billis, Cheng, Liang, Christopher Logothetis, David Esopi, Lotan, Tamara, Robin G. Lorenz, T L Lotan, T Lotan, T. L. Lotan, T. Lotan

702

Publications

16.1K

Citations

H-Index

118

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center Northwestern University University of Michigan

About

Tamara L. Lotan is an author at Johns Hopkins University specializing in medicine, urology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	71	5.7K
2	Engineering	4	4	155
3	Health Sciences	3	3	127
4	Natural Sciences	2	2	144
5	Public Health	2	2	246

Tamara L. Lotan

156

Publications

14.4K

Citations

H-Index

Page 1

	Year	Citations
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer Emmanuel S. Antonarakis, Changxue Lu, Hao Wang, New England Journal of Medicine	2014	2.6K
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation Jonathan I. Epstein, Mahul B. Amin, Himisha Beltran, The American Journal of Surgical Pathology Tumor BiologyUrologyOncologyGenitourinary CancerMedicine	2014	571
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes Christopher M. Heaphy, Andrea P. Subhawong, Seung‐Mo Hong, American Journal Of Pathology Human Cancer SubtypesMedicineAlternative LengtheningPathologyTelecare	2011	513
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Journal of the National Comprehensive Cancer Network UrologySurgical OncologyGenitourinary CancerMedicineCancer Management	2023	509
The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance Himisha Beltran, Andrew M. Hruszkewycz, Howard I. Scher, Clinical Cancer Research	2019	365
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma Hsueh-Li Tan, Hameed A. Rahimi, Wenle Wang, Clinical Cancer Research	2013	349
PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients Tamara L. Lotan, Bora Gürel, Siobhan Sutcliffe, Clinical Cancer Research	2011	347
Long Interspersed Element-1 Protein Expression Is a Hallmark of Many Human Cancers Nemanja Rodić, Reema Sharma, Rajni Sharma, American Journal Of Pathology	2014	342
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer Shusuke Akamatsu, Alexander W. Wyatt, Dong Lin, Cell Reports	2015	294
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials Matthew P. Deek, Kim Van der Eecken, Philip Sutera, Journal of Clinical Oncology	2022	222

Page 1